Laureano Simon

Dr. Laureanu Simon serves as Chief Executive Officer & is a Co-Founder at Oncomatryx. Founder of Oncomatryx and other biotech companies including Patia and Progenika, which he later sold to Grifols for 90m EnValue. Laureano has received the Euro awards Award for Entrepreneurs (2004), Ernst & Young Year's Most Innovative Entrepreneur (2010), and the Ruban d'honneur in the European Business Awards, HSBC Bank (2011). He holds a Ph.D. in Biochemistry and Molecular Biology from the Autonomous University of Madrid, an MSc in Biotechnology from the University of Navarre, an MSc from the University of Wisconsin-Madison, and a BSc in Pharmacy from the University of Santiago de Compostela. Laureano is an investor and member of the Board of Directors since 2016. He has founded, invested, and served as a director for over a dozen companies in the private biotech sector. Laureano was the founder and CEO of Progenika Biopharma, which he later sold to Grifols. Laureano has received the Eurowards Award for Entrepreneurs (2004), Ernst & Young Most Innovative Entrepreneur (2010), and the Ruban d'honneur in the European Business Awards, HSBC Bank (2011).